Clinical Trials Browser

Phase 2 × Breast Neoplasms × Nebivolol × Clear all

NCT07233499 2025-11-19

Evaluation of the Cardioprotective Effect of Nebivolol on Trastuzumab-Induced Cardiotoxicity in Breast Cancer Patients

Phase 2 Recruiting

Breast Neoplasms